Avatar
Monicasharma

0 Following 0 Followers
1
Read more about UK approves Pfizer-BioNTech Covid vaccine; to be available from next week on Business Standard. The U.K. had signaled it would move swiftly in approving a vaccine to protect its population, and doctors across the country were put on standby for a possible rollout
1
Read more about Bajaj Auto sales rise 5% to 4,22,240 units in Nov, domestic sales dip 4% on Business Standard. Bajaj Auto on Tuesday reported a 5 per cent increase in total sales to 4,22,240 units in November this year.The company had sold 4,03,223units in the same month a year ago.Domestic sales in November this year stood at 1,98,933 units as against
1
Read more about Maruti Suzuki's November sales increase 1.7 per cent to 153,223 units on Business Standard. Automobile major Maruti Suzuki reported a growth of 1.7 per cent in its overall sales during November 2020 on a year-on-year basis
1
Read more about Covid vaccine won't be released unless proven safe, assures Serum Institute on Business Standard. SII says after DSMB and ethics committee cleared they continued with the trials; sympathetic with the condition of the subject
1
Read more about India's disadvantaged lack nutrition, except we don't know how much on Business Standard. In India, caste is a dominant aspect of an individual's social identity and can similarly determine access to crucial health and nutrition services
1
Read more about Lakshmi Vilas customers to get all services; interest rates unchanged: DBS on Business Standard. The amalgamation of Lakshmi Vilas Bank into DBS Bank India came into effect from November 27
1
Read more about A 'mission of the century' as airlines prep for gargantuan vaccine supply on Business Standard. Laid low by a Covid-19 outbreak that's decimated passenger demand, airlines will be the workhorses of the attempt to eradicate it, hauling billions of vials to every corner of the globe
1
Read more about Covishield shows 60-70% efficacy; Modi to visit Serum Institute on Saturday on Business Standard. SII is unlikely to announce any interim data from the trials here. It will wait to compile and analyse data, before sharing it with the Indian regulator.